How are fetal alcohol spectrum disorders diagnosed? What are the primary and secondary disabilities associated with FASD? And - most important of all - what is the human cost? This program addresses these questions through the firsthand experiences of Ann Streissguth, director of the University of Washington’s Fetal Alcohol and Drug Unit; Kathy Mitchell, vice president of NOFAS; Erica Lara, who works at a residential drug and alcohol treatment facility designed especially for women with young children; and Erica Gitis-Miles, a college student who has FASD. The in utero effects of alcohol are considered as well, as are the facial, bodily, neurological, cognitive, and behavioral characteristics of FASD. *Closed Captioned